HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical.

Abstract
Given that Type-I photosensitizers (PSs) have hypoxia tolerance, developing general approaches to prepare Type-I PSs is of great importance, but remains a challenge. Here, we report a supramolecular strategy for the preparation of Type-I photodynamic agents, which simultaneously generate strong oxidizing cationic radicals and superoxide radicals, by introducing electron acceptors to the existing Type-II PSs. As a proof-of-concept, three electron acceptors were designed and co-assembled with a classical PS to produce quadruple hydrogen-bonded supramolecular photodynamic agents. The photo-induced electron transfer from the PS to the adjacent electron acceptor occurs efficiently, leading to the generation of a strong oxidizing PS+• and an anionic radical of the acceptor, which further transfers an electron to oxygen to form O2-•. In addition, these photodynamic agents induce direct photocatalytic oxidation of NADH with a turnover frequency as high as 53.7 min-1, which offers an oxygen-independent mechanism to damage tumors.
AuthorsKun-Xu Teng, Li-Ya Niu, Nan Xie, Qing-Zheng Yang
JournalNature communications (Nat Commun) Vol. 13 Issue 1 Pg. 6179 (10 19 2022) ISSN: 2041-1723 [Electronic] England
PMID36261451 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Chemical References
  • Superoxides
  • Photosensitizing Agents
  • NAD
  • Oxygen
  • Hydrogen
Topics
  • Superoxides
  • Photosensitizing Agents (pharmacology)
  • NAD (metabolism)
  • Oxidation-Reduction
  • Oxygen
  • Hydrogen
  • Photochemotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: